Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Guillermo Yoldi"'
Autor:
Clara Gómez-Aleza, Bastien Nguyen, Guillermo Yoldi, Marina Ciscar, Alexandra Barranco, Enrique Hernández-Jiménez, Marion Maetens, Roberto Salgado, Maria Zafeiroglou, Pasquale Pellegrini, David Venet, Soizic Garaud, Eva M. Trinidad, Sandra Benítez, Peter Vuylsteke, Laura Polastro, Hans Wildiers, Philippe Simon, Geoffrey Lindeman, Denis Larsimont, Gert Van den Eynden, Chloé Velghe, Françoise Rothé, Karen Willard-Gallo, Stefan Michiels, Purificación Muñoz, Thierry Walzer, Lourdes Planelles, Josef Penninger, Hatem A. Azim, Sherene Loi, Martine Piccart, Christos Sotiriou, Eva González-Suárez
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-18 (2020)
Receptor activator of nuclear factor-κB (RANK)/RANK-ligand (RANKL) signaling regulates the tumor-immune crosstalk. Here the authors show that systemic RANKL inhibition promotes CD8 + T cell infiltration in patients with early breast cancer and that
Externí odkaz:
https://doaj.org/article/25343e5b801f4662be448798ebe81a76
Autor:
Andrés Gámez-García, Idoia Bolinaga-Ayala, Guillermo Yoldi, Sergio Espinosa-Gil, Nora Diéguez-Martínez, Elisabet Megías-Roda, Pau Muñoz-Guardiola, Jose M. Lizcano
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Autophagy is a highly conserved intracellular process that preserves cellular homeostasis by mediating the lysosomal degradation of virtually any component of the cytoplasm. Autophagy is a key instrument of cellular response to several stresses, incl
Externí odkaz:
https://doaj.org/article/b087629e9a314cc7945f694a47bb7246
Autor:
Jorge Gómez-Miragaya, Marta Palafox, Laia Paré, Guillermo Yoldi, Irene Ferrer, Sergi Vila, Patricia Galván, Pasquale Pellegrini, Hector Pérez-Montoyo, Ana Igea, Purificación Muñoz, Manel Esteller, Angel R. Nebreda, Ander Urruticoechea, Idoia Morilla, Sonia Pernas, Fina Climent, María Teresa Soler-Monso, Ana Petit, Violeta Serra, Aleix Prat, Eva González-Suárez
Publikováno v:
Stem Cell Reports, Vol 8, Iss 5, Pp 1392-1407 (2017)
Taxanes are a mainstay of treatment for breast cancer, but resistance often develops followed by metastatic disease and mortality. Aiming to reveal the mechanisms underlying taxane resistance, we used breast cancer patient-derived orthoxenografts (PD
Externí odkaz:
https://doaj.org/article/4f17da8dcc6a4c1abea0af3c702c89e0
Autor:
Eva González-Suárez, Lourdes Planelles, Miguel-Angel Pujana, Purificación Muñoz, William C. Dougall, Jordi Serra-Musach, Jorge Gomez-Miragaya, Alex Cordero, Eva M. Trinidad, Pasquale Pellegrini, Guillermo Yoldi
Legend for Supplementary Table S1 and Supplementary Figures S1-S5.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a8e7df58d3ed33c36c982b0dedddf59
https://doi.org/10.1158/0008-5472.22408430.v1
https://doi.org/10.1158/0008-5472.22408430.v1
Autor:
Eva González-Suárez, Lourdes Planelles, Miguel-Angel Pujana, Purificación Muñoz, William C. Dougall, Jordi Serra-Musach, Jorge Gomez-Miragaya, Alex Cordero, Eva M. Trinidad, Pasquale Pellegrini, Guillermo Yoldi
Knock-down and overexpression of Tfap2b and Knock down of Rank
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03eed525a038e3ba91be3df2865aaef0
https://doi.org/10.1158/0008-5472.22408442.v1
https://doi.org/10.1158/0008-5472.22408442.v1
Autor:
Eva González-Suárez, Lourdes Planelles, Miguel-Angel Pujana, Purificación Muñoz, William C. Dougall, Jordi Serra-Musach, Jorge Gomez-Miragaya, Alex Cordero, Eva M. Trinidad, Pasquale Pellegrini, Guillermo Yoldi
Description of additional methods and procedures used in the study. Also includes Supplementary References.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bdcd747924fdd9cc09782795aaf8948
https://doi.org/10.1158/0008-5472.22408436
https://doi.org/10.1158/0008-5472.22408436
Autor:
Eva González-Suárez, Lourdes Planelles, Miguel-Angel Pujana, Purificación Muñoz, William C. Dougall, Jordi Serra-Musach, Jorge Gomez-Miragaya, Alex Cordero, Eva M. Trinidad, Pasquale Pellegrini, Guillermo Yoldi
RANK expression is associated with poor prognosis in breast cancer even though its therapeutic potential remains unknown. RANKL and its receptor RANK are downstream effectors of the progesterone signaling pathway. However, RANK expression is enriched
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4683296f424049bd54c2ec9d3ccf6a32
https://doi.org/10.1158/0008-5472.c.6507533
https://doi.org/10.1158/0008-5472.c.6507533
Autor:
Eva González-Suárez, Lourdes Planelles, Miguel-Angel Pujana, Purificación Muñoz, William C. Dougall, Jordi Serra-Musach, Jorge Gomez-Miragaya, Alex Cordero, Eva M. Trinidad, Pasquale Pellegrini, Guillermo Yoldi
Genes differentially regulated by adjuvant and neoadjuvant RANK-Fc treatments.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59e1d7f343c1acf1654845d258addbda
https://doi.org/10.1158/0008-5472.22408433
https://doi.org/10.1158/0008-5472.22408433
Autor:
Nora Diéguez-Martínez, Sergio Espinosa-Gil, Guillermo Yoldi, Elisabet Megías-Roda, Idoia Bolinaga-Ayala, Maria Viñas-Casas, Gokhan Gorgisen, Inés Domingo-Ortí, Héctor Pérez-Montoyo, Jose R. Bayascas, Eva Colas, Xavier Dolcet, Jose M. Lizcano
Publikováno v:
Scientia
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Apoptosis; Endometrial cancer; Map kinase Apoptosis; Cáncer endometrial; Mapa quinasa Apoptosi; Càncer d'endometri; Mapa quinasa Endometrial cancer (EC) is the most common type of gynecologic cancer in women of developed countries. Despite surgery
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ee209282eb349c6036150295fb11f1b
https://hdl.handle.net/11351/8468
https://hdl.handle.net/11351/8468
Autor:
Thierry Walzer, Josef M. Penninger, Peter Vuylsteke, Gert Van den Eynden, Bastien Nguyen, Eva González-Suárez, Sherene Loi, Soizic Garaud, C. Velghe, David Venet, Françoise Rothé, Purificación Muñoz, Lourdes Planelles, Enrique Hernández-Jiménez, Philippe Simon, Hans Wildiers, Eva M. Trinidad, Sandra Benítez, Hatem A. Azim, Guillermo Yoldi, Christos Sotiriou, Roberto Salgado, Geoffrey J. Lindeman, Maria Zafeiroglou, Marina Ciscar, Alexandra Barranco, Stefan Michiels, Clara Gómez-Aleza, Martine Piccart, Laura Polastro, Karen Willard-Gallo, Pasquale Pellegrini, Marion Maetens, Denis Larsimont
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-18 (2020)
Nature Communications
Nature communications, 11 (1
Repisalud
Instituto de Salud Carlos III (ISCIII)
Nature Communications
Nature communications, 11 (1
Repisalud
Instituto de Salud Carlos III (ISCIII)
Most breast cancers exhibit low immune infiltration and are unresponsive to immunotherapy. We hypothesized that inhibition of the receptor activator of nuclear factor-κB (RANK) signaling pathway may enhance immune activation. Here we report that los